| 证券代码：301069 | 证券简称：凯盛新材 | 公告编号：2025-072 | | --- | --- | --- | | 债券代码：123233 | 债券简称：凯盛转债 | | 山东凯盛新材料股份有限公司 关于公司控股股东拟发行可交换公司债券的公告 本公司及董事会全体成员保证公告内容真实、准确和完整，并对公告中的 虚假记载、误导性陈述或者重大遗漏承担责任。 山东凯盛新材料股份有限公司（以下简称"公司"）近日收到控股股东华邦 生命健康股份有限公司（以下简称"华邦健康"）的书面通知，华邦健康拟以其 直接持有本公司的部分 A 股股票为标的非公开发行可交换公司债券（以下简称 "本次可交换债券"）。 华邦健康目前直接持有公司 126,755,153 股 A 股股份，占公司总股本的 29.61%。本次可交换债券的期限不超过（含）3 年，总规模不超过 10 亿元人民 币(含 10 亿元人民币)，可一次发行或分期发行。具体期限、发行规模和期次由 华邦健康股东会授权董事会(或董事会授权人士)根据资金需求情况和发行时的 市场情况与主承销商在上述范围内协商确定。债券每张票面金额为 100 元，按面 值平价发行。 特此公告 ...

| 证券代码：301069 | 证券简称：凯盛新材 | 公告编号：2025-071 | | --- | --- | --- | | 债券代码：123233 | 债券简称：凯盛转债 | | 山东凯盛新材料股份有限公司 关于提前赎回"凯盛转债"的第一次提示性公告 本公司及董事会全体成员保证公告内容真实、准确和完整，并对公告中的 虚假记载、误导性陈述或者重大遗漏承担责任。 特别提示： 赎回价格：100.10 元/张（含息、税） 赎回条件满足日：2025 年 12 月 22 日 赎回登记日：2026 年 1 月 14 日 赎回日：2026 年 1 月 15 日 停止交易日：2026 年 1 月 12 日 停止转股日：2026 年 1 月 15 日 发行人（公司）资金到账日：2026 年 1 月 20 日 投资者赎回款到账日：2026 年 1 月 22 日 赎回类别：全部赎回 最后一个交易日可转债简称：Z 盛转债 根据安排，截至 2026 年 1 月 14 日收市后仍未转股的"凯盛转债"将被强 制赎回，特提醒"凯盛转债"持有人注意在限期内转股。本次赎回完成后，"凯 盛转债"将在深圳证券交易所摘牌。"凯盛转债"持有人持有 ...

Core Viewpoint - Huabang Health (002004.SZ) has announced the approval of several proposals regarding the issuance of non-public technology innovation exchangeable corporate bonds, which will be submitted for shareholder meeting review [1] Group 1: Bond Issuance Details - The company plans to issue exchangeable corporate bonds that can be exchanged for shares of Shandong Kaisheng New Materials Co., Ltd. (stock code: 301069.SZ) [1] - The total scale of the bond issuance is not to exceed 1 billion RMB (including 1 billion RMB), which can be issued in one go or in multiple phases [1] - The specific issuance scale and timing will be determined by the board of directors based on the company's funding needs and market conditions, with authorization from the shareholder meeting [1] Group 2: Board Meeting Resolutions - The fourth meeting of the ninth board of directors reviewed and approved the proposals related to the bond issuance [1] - The proposals include the conditions for the non-public issuance of technology innovation exchangeable corporate bonds and the authorization for the board to handle related matters [1]

Core Viewpoint - Huabang Health (002004.SZ) has announced the approval of several proposals regarding the issuance of non-public technology innovation exchangeable corporate bonds, which will be submitted for shareholder meeting review [1] Group 1: Bond Issuance Details - The company plans to issue exchangeable corporate bonds targeting professional institutional investors, with a total scale not exceeding 1 billion RMB (including 1 billion RMB) [1] - The bonds will be exchangeable for shares of Shandong Kaisheng New Materials Co., Ltd. (stock code: 301069.SZ) [1] - The specific issuance scale and timing will be determined by the board of directors based on the company's funding needs and market conditions, with authorization from the shareholder meeting [1] Group 2: Board Meeting Resolutions - The fourth meeting of the ninth board of directors reviewed and approved the proposals related to the bond issuance [1] - The proposals include the conditions for the issuance of the exchangeable bonds and the authorization for the board to handle related matters [1]

格隆汇12月23日丨凯盛新材(301069.SZ)在互动平台表示，公司的PEKK产品已被广泛应用于多个领域， 包括通用型材、喷涂、新能源汽车、军工航空航天等。同时，公司也在紧密跟踪电子信息（半导体）、 康复医疗器械、机器人等领域对于轻量化特种材料的发展动向并积极开拓国内外市场。公司暂不知晓 PEKK产品是否间接被应用于液冷服务器系统领域中。 ...

格隆汇12月23日丨凯盛新材(301069.SZ)在互动平台表示，公司的PEKK产品已被广泛应用于多个领域， 包括通用型材、喷涂、新能源汽车、军工航空航天等。同时，公司也在紧密跟踪电子信息（半导体）、 康复医疗器械、机器人等领域对于轻量化特种材料的发展动向并积极开拓国内外市场。公司暂不知晓 PEKK产品是否间接被应用于液冷服务器系统领域中。 ...

人民财讯12月23日电，凯盛新材（301069）12月23日在互动平台表示，因需求端拉动，今年以来公司氯 化亚砜产能利用率一直维持在高位。近期氯化亚砜售价涨幅明显，但其售价受到原材料采购成本、市场 供求关系等多种因素影响，因此无法对其未来售价进行预估。 ...

Summary of Key Points from the Conference Call Company Overview - The company discussed is **凯盛新材 (Kaisheng New Materials)**, focusing on the chlorosulfonic acid and lithium battery materials sectors. Industry Insights - **Chlorosulfonic Acid Pricing**: Prices are expected to remain high, influenced by sustained demand and rising sulfur costs. Current pricing is above **3,000 RMB** per ton, with some exceeding **4,000 RMB** [2][6] - **Sulfur Costs**: The cost of sulfur is a significant factor, with each ton of chlorosulfonic acid requiring approximately **700-800 RMB** in sulfur costs [2][7] - **Lithium Battery Market**: Demand for cobalt chloride in lithium batteries is projected to increase, with prices for lithium battery-grade products reaching **7,000 RMB** per ton by 2025 [2][8] - **Agricultural Products**: The agricultural sector is performing well, with significant increases in export volumes expected in 2025. The company anticipates a positive outlook for the agricultural segment in Q1 2026 [2][14][16] Financial Performance - **Gross Margin**: The gross margin for chlorosulfonic acid is estimated to be around **20%-30%**, with potential for higher margins if prices remain above **3,000 RMB** [2][18] - **Convertible Bonds**: The company may save on financial costs through the redemption of convertible bonds or large-scale conversions, potentially releasing at least **30 million RMB** in profits [2][19] Production and Capacity - **Production Capacity**: The company currently operates at nearly **100%** capacity with no immediate plans for expansion in chlorosulfonic acid production [2][17] - **PEKK Production**: The company maintains a production yield of over **80%** for PEKK, with plans to increase production capacity to **1,000 tons** next year [2][30] Market Dynamics - **Demand Drivers**: Recent demand increases are attributed to market supply shortages and issues with certain manufacturers, enhancing the company's pricing power [2][9] - **Stability in Food Additives**: Demand for food additives remains stable, categorized as a necessity [2][13] - **PEKK Market Position**: The company is a leading domestic producer of PEKK, with limited competition in large-scale production [2][27] Future Outlook - **Q4 Profit Expectations**: The company expects improved profitability in Q4 compared to previous quarters, although financial adjustments may affect final results [2][25] - **Investment in Lithium Battery Sector**: The company is focusing on the lithium battery and green chemical sectors, postponing investments in less attractive projects [2][24] Additional Considerations - **Market Trends**: The company is observing trends in the sulfur market, with potential impacts from refinery output and stockpiling by certain firms [2][11] - **Specialty Robotics**: The demand for high-end materials in specialty robotics applications is increasing, driven by the need for materials that meet specific performance criteria [2][29]

（文章来源：证券日报） 证券日报网讯 12月22日晚间，凯盛新材发布公告称，公司第四届董事会第五次会议审议通过《关于提 前赎回"凯盛转债"的议案》。 ...

2025年1至6月份，凯盛新材的营业收入构成为：化工新材料占比99.42%，其他业务占比0.58%。 截至发稿，凯盛新材市值为119亿元。 每经AI快讯，凯盛新材（SZ 301069，收盘价：28.29元）12月22日晚间发布公告称，公司第四届第五次 董事会会议于2025年12月22日通过通讯表决的方式召开。会议审议了《关于提前赎回"凯盛转债"的议 案》。 每经头条（nbdtoutiao）——新能源重卡爆单了，11月销量同比增长178%！两班倒都供不应求，客户直 接进厂催单，这情景十年难遇 （记者 贾运可） ...